MARKET

SPRO

SPRO

Spero Therapeuti
NASDAQ
2.330
-0.020
-0.85%
After Hours: 2.280 -0.05 -2.15% 19:54 02/18 EST
OPEN
2.350
PREV CLOSE
2.350
HIGH
2.405
LOW
2.315
VOLUME
266.05K
TURNOVER
--
52 WEEK HIGH
3.220
52 WEEK LOW
0.5052
MARKET CAP
131.27M
P/E (TTM)
-2.9312
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SPRO last week (0209-0213)?
Weekly Report · 2d ago
Trade Alert: CEO, CFO Of Spero Therapeutics Esther Rajavelu Has Sold Stock
Simply Wall St · 4d ago
Spero Therapeutics: Tebipenem's FDA Path Supports A Speculative Buy
Seeking Alpha · 02/11 13:43
Weekly Report: what happened at SPRO last week (0202-0206)?
Weekly Report · 02/09 09:48
Top Executive’s Sudden Stock Move Sends a New Signal at Spero Therapeutics
TipRanks · 02/06 02:01
Weekly Report: what happened at SPRO last week (0126-0130)?
Weekly Report · 02/02 09:47
Spero Therapeutics Co-Founder Resigns From Board Roles
TipRanks · 01/30 22:32
Spero Therapeutics CEO Ankit Mahadevia Resigns Effective January 2026
Reuters · 01/30 22:01
More
About SPRO
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying and developing novel treatments for rare diseases and diseases caused by multi-drug resistant (MDR) bacterial infections with unmet need. Its product candidate SPR720 is an investigational, chemically stable phosphate ester prodrug that is converted in vivo to SPR719 for the treatment of nontuberculous mycobacterial (NTM) pulmonary disease. Its clinical stage product candidate, tebipenem HBr is an investigational oral carbapenem antibiotic being developed for the treatment of complicated urinary tract infections (cUTIs) including acute pyelonephritis (AP) to help patients potentially reduce duration of in-patient therapy.

Webull offers Spero Therapeutics Inc stock information, including NASDAQ: SPRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPRO stock methods without spending real money on the virtual paper trading platform.